Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50357907 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_787640 (CHEMBL1918093) | ||
| IC50 | 29±n/a nM | ||
| Citation |  Lumeras, W; Vidal, L; Vidal, B; Balagué, C; Orellana, A; Maldonado, M; Domínguez, M; Segarra, V; Caturla, F 1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase. J Med Chem54:7899-910 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50357907 | |||
| n/a | |||
| Name | BDBM50357907 | ||
| Synonyms: | CHEMBL1916521 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C25H13Cl3FN3O | ||
| Mol. Mass. | 496.748 | ||
| SMILES | [O-][n+]1ccc2c(cc(nc2c1-c1c(Cl)cccc1Cl)-c1ccncc1)-c1ccc(F)cc1Cl |(7.36,-4.61,;8.69,-3.84,;8.7,-2.3,;10.03,-1.52,;11.36,-2.29,;12.7,-1.51,;14.04,-2.29,;14.03,-3.84,;12.69,-4.61,;11.36,-3.84,;10.03,-4.61,;10.03,-6.14,;8.7,-6.92,;7.36,-6.15,;8.7,-8.46,;10.04,-9.23,;11.37,-8.44,;11.37,-6.91,;12.7,-6.13,;15.36,-4.61,;15.36,-6.15,;16.69,-6.92,;18.03,-6.16,;18.03,-4.61,;16.69,-3.84,;12.7,.02,;14.03,.79,;14.03,2.33,;12.7,3.1,;12.7,4.64,;11.36,2.32,;11.37,.79,;10.03,.01,)| | ||
| Structure | 
| ||